Intel reports financial results for the third quarter on Thursday after the bell. Here's a look at the key metrics from the ...
Hims & Hers Health, Inc. offers 30% upside to $64 based on management guidance with potential rerating to $353. Learn more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback